Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 4

Endotelyal progenitor hücreler (CD34+KDR+) ve monositler vasküler risk faktörleri ve yaygın ateroskleroza rağmen iyi koroner kollateral gelişimini sağlayabilirler

Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis

Pages
290–299
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among the patients with CAD, the percent degree of luminal stenosis was

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Endothelial progenitor cells (EPC) have a regenerative role in the vascular system.
📊
Key Findings & Data:We enrolled 112 eligible patients who underwent coronary angiography consecutively (mean age: 59±9 years).
💡
Conclusion & Impact:Among the patients with CAD, the percent degree of luminal stenosis was
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Endothelial progenitor cells (EPC) have a regenerative role in the vascular system. In this study, we aimed to evaluate simultaneously the effects of EPC and inflammatory cells on the presence and the extent of coronary artery disease (CAD) and the grade of coronary collateral growth in patients with clinical suspicion of CAD.Methods: This study has a cross-sectional and observational design. We enrolled 112 eligible patients who underwent coronary angiography consecutively (mean age: 59±9 years). The association of circulating inflammatory cells and EPC (defined by CD34+KDR+ in the lymphocyte and monocyte gate) with the presence, severity and extent of CAD and the degree of collateral growth were investigated. Logistic regression analysis was used to define the predictors of collateral flow. Results: Of 112 patients 30 had normal coronary arteries (NCA, 27%, 55±9 years) and 82 had CAD (73%, 61±8 years). Among the patients with CAD, the percent degree of luminal stenosis was

Özet

Amaç: Endoteliyal progenitör hücreler (EPH) vasküler sistemde onarıcı bir role sahiptir. Bu çalışmanın amacı kandaki enflamatuvar hücreler ve EPH’lerin, kardiyovasküler risk faktörleri ile birlikte ateroskleroz varlığı ve yaygınlığı ile ilişkisinin araştırılması ve koroner kollateral gelişim üzerine olan etkilerinin incelenmesidir. Yöntemler: Bu çalışma enine-kesitli ve gözlemsel bir modele sahiptir. Çalışmaya koroner anjiyografisi yapılan ardışık 112 hasta alındı (ortalama yaş: 59±9 yıl). Periferik kanda dolaşan enflamasyon hücreleri ve EPH (lenfositer ve monositer alanda CD34+KDR+ olarak tanımlanan) hücrelerin ateroskleroz varlığı, ciddiyeti, yaygınlığı ve kollateral gelişimi ile olan ilişkileri araştırıldı. Kollateral akım öngördürücülerinin belirlenmesinde lojistik regresyon analizi kullanıldı. Bulgular: Yüz on iki hastanın 30’unda normal koroner arterler (NKA, %27, 55±9 yıl), 82’sinde koroner arter hastalığı bulunduğu saptandı (KAH, %73, 61±8 yıl). Koroner arter hastalığı saptanan hastalar arasında 12 hastanın koroner arterinde

🔖

Cite This Article

BOYACI, B., TİMURKAYNAK, T., KURŞUNLUOĞLU, N., YAĞCI, M., ABACI, A., TÜRKOĞLU, S., ŞAHİN, A. A., ÇENGEL, A., CEMRİ, M., KOCAMAN, S. A., YALÇIN, M. R., ÖZDEMİR, M., ARSLAN, U. (2022). Endotelyal progenitor hücreler (CD34+KDR+) ve monositler vasküler risk faktörleri ve yaygın ateroskleroza rağmen iyi koroner kollateral gelişimini sağlayabilirler. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 4, 290–299. https://ajindex.com/articles/648453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9
  2. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977; 86: 675-84
  3. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003; 108: 1520-6
  4. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-84
  5. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-63
  6. Wassmann S, Werner N, Czech T, Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006; 99: e74-83
  7. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI investigators. Circulation 1991; 83: 739-46
  8. Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989; 117: 290-5
  9. Matsuo Y, Imanishi T, Hayashi Y, Tomobuchi Y, Kubo T, Hano T, et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med 2008; 47: 127-34
  10. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004; 109: 2986-92
  11. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606
  12. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502
  14. Asahara T, Muro